Status:
NOT_YET_RECRUITING
A Cryotherapy With Tranexamic Acid Versus Normal Saline in the Treatment of Melasma
Lead Sponsor:
Mahidol University
Conditions:
Cryotherapy Effect
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
This study aimed to evaluate the effectiveness of a precision cryotherapy via boosting mode combined with tranexamic acid versus normal saline in the treatment of melasma. Eighteen patients aged 25 to...
Detailed Description
TargetCool via boosting mode combined with tranexamic acid versus normal saline were studied in patients diagnosed with epidermal-typed melasma.
Eligibility Criteria
Inclusion
- The patients diagnosed with epidermal-type melasma sized equal to or more than 2 cm on both sides of cheeks
- Fitzpatrick skin type II-IV
Exclusion
- Pregnant or lactation
- Subjects who have been treated with any kind of energy-based device 6 months prior to the inclusion
- Subjects who have been treated with topical or oral treatment for melasma 6 months prior to the inclusion
- Subjects who allergy to cryotherapy such as cryoglobulinemia, cold urticaria, and abnormal cold tolerance
- Subjects with abnormal sensation such as diabetes mellitus
- Active skin infections
- History of hypertrophic scars or keloids History of hypertrophic scars or keloids
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06491771
Start Date
July 1 2024
End Date
July 1 2025
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Siriraj Hospital, Mahidol University
Bangkok, Thailand, 10700